Demographic characteristics of 11 patients with rheumatoid arthritis (RA)
| Total: 11 patients with RA (%) | |
|---|---|
| Gender, female n (%) | 11 (100) |
| Age, mean (SD) | 54.18±13.24 |
| Autoantibodies: | |
| RF positive n (%) | 9 (81.8) |
| ACPA positive n (%) | 9 (81.8) |
| Disease duration (years), mean (SD) | 14.20±6.42 |
| Baseline DAS28, mean (SD) | 5.45±1.13 |
| Time under Ifx therapy in years, mean (SD) | 8.00±2.75 |
| ATI duration in years, mean (SD) | 1.1±0.91 |
| Concomitant treatment | |
| MTX alone | 3 (27.2) |
| OD | 1 (9.0) |
| MTX+OD | 6 (54.8) |
| Ifx monotherapy | 1 (9.0) |
ACPA, Anticitrullinated protein antibody; ATI, antibodies to infliximab; DAS28, Disease Activity Score 28; Ifx, infliximab; MTX, Methotrexate; OD, Other DMARDs; RF, Rheumatoid Factor.